📅 PUBMED DAILY TRIAGE — 2026-11-06 Window: 2026-11-05T00:00:00Z → 2026-11-06T10:42:51Z (CRDT) Topics scanned: 10 | Articles reviewed: 119 | Candidates evaluated: 130 High priority: 6 | Standard: 33 | Low/archive: 80 | Unsolicited finds: 3 Run status: SUCCESS
🔴🟠 HIGH PRIORITY (8+ OR QUALIFYING FLAG) — Best Finds by Topic
Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma)
PMID-42986895 · Tyrosine kinase inhibitors are associated with reduced AML transformation in systemic mastocytosis with myeloid neoplasm. · 8/10 · Direct clinical outcome data in a rare, high-risk myeloid population support high-priority follow-up, with confounding risk from the observational design.
Early cancer detection (liquid biopsy, ctDNA, cfDNA)
PMID-42986194 · Comparison of Two Deep Learning Models and Their Combination for 1-year Lung Cancer Detection in Two Screening Cohorts. · 8/10 · Independent screening-cohort validation with reported AUC and sensitivity directly addresses early cancer detection and clinical AI. PMID-42985276 · Enhanced Esophageal Cancer Detection Using Spectrum-Aided Vision Enhancer: A Comparative Study of White Light Imaging, Narrow-Band Imaging, and Algorithmic Narrow-Band Imaging-Like Imaging. · 7/10 · The study directly reports performance of an early cancer-detection method, qualifying for the flag while remaining exploratory because of retrospective design and dysplasia limitations.
AI/ML in clinical diagnostics and imaging
PMID-42988369 · Opportunistically Detecting Signs of Hypertension on a Consumer Smartwatch. · 9/10 · Prospective multicenter validation against a clinical reference standard gives this AI diagnostic study strong near-term population-health relevance. PMID-42986194 · Comparison of Two Deep Learning Models and Their Combination for 1-year Lung Cancer Detection in Two Screening Cohorts. · 8/10 · Independent screening-cohort validation with reported AUC and sensitivity directly addresses early cancer detection and clinical AI.
Novel therapeutics: immunotherapy, CAR-T, targeted therapy
PMID-42988049 · Soxataltinib, a highly selective CNS-penetrant RET inhibitor demonstrates durable activity in RET fusion-positive non-small cell lung cancer phase 2 study. · 8/10 · Strong phase 2 response data in a molecularly defined cancer population merit high-priority downstream review despite the absence of a randomized comparator. PMID-42988007 · Five-Year Follow-Up of ZUMA-3: A Phase 1/2 Study of Brexucabtagene Autoleucel for the Treatment of Patients With Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia. · 8/10 · Long-term CAR-T response and survival outcomes meet the novel-treatment flag rule and are directly relevant to a high-unmet-need hematologic malignancy.
🟢⚪ STANDARD (5-7) — Top by Topic
Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma)
PMID-42988566 · Clinical Study Protocol for PENTILULA: A Phase 1/2 Study Assessing [(177)Lu]Lu-Pentixather for Relapsed or Refractory CXCR4-Positive Acute Leukemia. · 6/10 · Treatment Innovation PMID-42988006 · Impact of Venetoclax Bridging on Haematopoietic Stem Cell Transplantation Outcomes in Advanced Myelodysplastic Neoplasms. · 6/10 · Treatment Innovation PMID-42987335 · Quantitative and mutational properties in the ctDNA uncovered by systemic inflammation in large B-cell lymphoma. · 6/10 · Genomics/Precision Medicine PMID-42986560 · Molecular and clinical profiling of SF3B1, U2AF1, and SRSF2 mutations in Iranian patients with myelodysplastic neoplasms. · 6/10 · Genomics/Precision Medicine
CBC-based diagnostics and machine learning in hematology
No standard-priority retained articles today.
Early cancer detection (liquid biopsy, ctDNA, cfDNA)
PMID-42988166 · [Place of clinical breast examination in breast cancer screening strategies. French College of Gynecologists and Obstetricians (CNGOF) recommendations for clinical practice]. · 7/10 · Prevention PMID-42988126 · Serum Metabolomic Profiling of Breast Cancer and Its Clinicopathological Associations. · 6/10 · Early Detection
AI/ML in clinical diagnostics and imaging
PMID-42988655 · Deep learning denoising and positron range correction of clinical [(68)Ga]Ga-DOTA-TOC PET images. · 6/10 · Diagnostics PMID-42988631 · Deep Learning-Based Gadolinium-Free Virtual Contrast-Enhanced MRI for Predicting Immediate HIFU Ablation Outcomes in Uterine Fibroids. · 6/10 · Diagnostics PMID-42988718 · Clinical Praat Parameters and Cepstral Representations for Speaker-Independent Voice Pathology Detection: The Influence of Age and Dysphonia Severity. · 5/10 · Diagnostics
Precision oncology and genomic medicine
PMID-42986560 · Molecular and clinical profiling of SF3B1, U2AF1, and SRSF2 mutations in Iranian patients with myelodysplastic neoplasms. · 6/10 · Genomics/Precision Medicine PMID-42986361 · Latest Research Progress on Drug Treatment for Intrahepatic Cholangiocarcinoma. · 6/10 · Treatment Innovation PMID-42985462 · Ovarian Carcinoma: Signal Pathways and Clinical Studies. · 6/10 · Genomics/Precision Medicine PMID-42984918 · Targeting ATM Kinase in Cancer-A Comprehensive Review. · 6/10 · Genomics/Precision Medicine
Novel therapeutics: immunotherapy, CAR-T, targeted therapy
PMID-42987884 · Activity and safety of first-line pumitamig plus nab-paclitaxel in triple-negative breast cancer: a single-arm, phase 1b/2 trial. · 7/10 · Treatment Innovation PMID-42988230 · Endothelial senescence orchestrates the tumor immune microenvironment and immunotherapy response in non-small cell lung cancer. · 6/10 · Treatment Innovation PMID-42985244 · Triaptosis-based biomimetic nanoparticle for the treatment of oral squamous cell carcinoma lymph node metastasis. · 5/10 · Drug Development
Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk
PMID-42987980 · The effect of subcutaneous semaglutide injection on blood pressure: a systematic review and meta-analysis of randomized controlled trials. · 7/10 · Prevention PMID-42986435 · Serum sodium and chloride interplay and the effect of empagliflozin in heart failure: an EMPEROR-Pooled analysis. · 7/10 · Treatment Innovation PMID-42988105 · Associations between Antidiabetic Drug Classes and Aortic Aneurysm Risk in Patients with Type 2 Diabetes: A Nationwide Cohort Study. · 6/10 · Prevention PMID-42986797 · Plant-Forward Dietary Patterns and Cardiometabolic Risk Among US Adults: Findings From the National Health and Nutrition Examination Survey, 2009-2023. · 6/10 · Public Health PMID-42988221 · Semaglutide Versus Diet-Based Weight Loss in Obesity and Heart Failure with Reduced Ejection Fraction (FIT-HF): Protocol for a Randomized Controlled Trial. · 5/10 · Treatment Innovation
Aging, longevity, and population health
PMID-42987245 · Association of LATE-NC With Neuropathologic Lesions and Cognitive Abilities: A Population-Based Autopsy Study. · 6/10 · Public Health PMID-42986567 · Non-linear associations between parity and long-term risk of osteoporosis. · 6/10 · Prevention PMID-42986480 · Feasibility and tolerability of combining 6 Hz transcranial alternating current stimulation (tACS) at 3.2 mA and digital cognitive training in older adults with mild cognitive impairment. · 6/10 · Treatment Innovation PMID-42986267 · Changes in Patterns of Health Care Use Among Older Adults in Singapore Across a Decade: Repeated Nationwide Cross-Sectional Survey. · 6/10 · Public Health PMID-42986592 · Navigating Outdoor Activities During Heatwaves: Heat Resilience Insights from a Focus Group Study with Urban-Dwelling Older Adults in Sweden. · 5/10 · Public Health
Rare diseases with high unmet need
PMID-42984386 · Adeno-associated virus gene therapy for hemophilia B: a comparative appraisal of the licensed products. · 7/10 · Treatment Innovation PMID-42983751 · The impact of national reimbursement drug negotiation on hospital procurement of rare disease drugs: an interrupted time series analysis. · 7/10 · Public Health PMID-42984810 · Willingness to adopt gene therapy for Duchenne muscular dystrophy: barriers, facilitators, and multidisciplinary readiness. · 6/10 · Treatment Innovation PMID-42983835 · Patient-reported experiences of people living with a rare disease with secondary and tertiary care: a scoping review. · 6/10 · Public Health PMID-42983856 · Implementation gaps in phenylketonuria management: a multicenter clinician survey from Turkiye. · 5/10 · Public Health
Sentinel scan
PMID-42985783 · Effectiveness of a Structured Post-Platelet Rich Plasma Rehabilitation Approach on Pain and Function in Subacromial Pain Syndrome: A Randomized Controlled Trial. · 7/10 · Treatment Innovation PMID-42985619 · DUF6383-domain containing protein from Parabacteroides distasonis predicts survival in patients with alcohol-associated hepatitis. · 6/10 · Diagnostics PMID-42986771 · Beyond Metastatic Lymphadenopathy in Breast Cancer: Approach to Axillary Masses. · 5/10 · Diagnostics
💡 UNSOLICITED FINDS
PMID-42985783 · Effectiveness of a Structured Post-Platelet Rich Plasma Rehabilitation Approach on Pain and Function in Subacromial Pain Syndrome: A Randomized Controlled Trial. · 7/10 · Treatment Innovation PMID-42985619 · DUF6383-domain containing protein from Parabacteroides distasonis predicts survival in patients with alcohol-associated hepatitis. · 6/10 · Diagnostics PMID-42986771 · Beyond Metastatic Lymphadenopathy in Breast Cancer: Approach to Axillary Masses. · 5/10 · Diagnostics
📊 TODAY'S BREAKDOWN
- By research category: Treatment Innovation 14, Public Health 7, Diagnostics 6, Prevention 4, Genomics/Precision Medicine 4, Early Detection 3, Drug Development 1
- By evidence maturity: Validated 22, Exploratory 17
- By watchlist topic:
- Hematologic malignancies (AML, MDS, CLL, MPN, lymphoma): 15 reviewed / 5 kept / highest 8/10
- CBC-based diagnostics and machine learning in hematology: 0 reviewed / 0 kept / highest 0/10
- Early cancer detection (liquid biopsy, ctDNA, cfDNA): 15 reviewed / 4 kept / highest 8/10
- AI/ML in clinical diagnostics and imaging: 15 reviewed / 5 kept / highest 9/10
- Precision oncology and genomic medicine: 15 reviewed / 4 kept / highest 6/10
- Novel therapeutics: immunotherapy, CAR-T, targeted therapy: 15 reviewed / 5 kept / highest 8/10
- Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk: 15 reviewed / 5 kept / highest 7/10
- Aging, longevity, and population health: 15 reviewed / 5 kept / highest 6/10
- Rare diseases with high unmet need: 15 reviewed / 5 kept / highest 7/10
- Sentinel scan: 10 reviewed / 5 kept / highest 8/10
- By source type: peer_reviewed 39 | preprint 0
- Topics with zero 8+ or qualifying-flag articles this run: CBC-based diagnostics and machine learning in hematology; Precision oncology and genomic medicine; Cardiovascular-metabolic: GLP-1, SGLT2, cardiometabolic risk; Aging, longevity, and population health; Rare diseases with high unmet need
🔧 RUN NOTES
- Same-date rerun regenerated the complete capped daily corpus; prior emission was used only for duplicate-alert suppression.
- All NCBI E-utilities calls used the supplied API key parameter and the required web_fetch transport; web_search confirmed the E-utilities endpoint documentation.
- ESummary was retrieved in batches of no more than five PMIDs; three truncated batches were recovered by individual web_fetch retries.
- EFetch abstract text was retrieved in batches of two PMIDs and independently reconciled for all selected candidates.
- CBC/ML hematology primary and required fallback searches both returned zero candidates.
- No Telegram alerts were emitted by this triage attempt.
- Coverage: 119 unique PMIDs independently reconciled in ESummary and EFetch; no missing PMIDs.
- Per-topic review caps were 15, with the sentinel capped at 10; no cap was exceeded.